FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Thierry Conroy, Pascal Hammel, Mohamed Hebbar, Méher Ben Abdelghani, Alice C. Wei, Jean‐Luc Raoul, Laurence Choné, E. François, Pascal Artru, James Biagi, Thierry Lecomte, Eric Assénat, Roger Faroux, Marc Ychou, Julien Volet, Alain Sauvanet, Gilles Breysacher, Frédéric Di Fiore, C. Cripps, Petr Kavan, Patrick Texereau, Karine Bouhier‐Leporrier, Faiza Khemissa-Akouz, Jean-Louis Legoux, Béata Juzyna, Sophie Gourgou, Christopher J. O’Callaghan, Claire Jouffroy-Zeller, Patrick Rat, David Malka, Florence Castan, Jean‐Baptiste Bachet
New England Journal of Medicine, 2018
Abstract
This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).